LifeMD, Inc.: Form 10-Q/A for the period ended Sep 30, 2018
Filed with the SEC on Dec 4, 2018 and accepted by EDGAR at Dec 4, 2018, 11:56 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-07-01 to 2018-09-30 | $2.5m | us-gaap:Revenues |
| Revenue | 9 months2018-01-01 to 2018-09-30 | $6.1m | us-gaap:Revenues |
| Cost of revenue | 3 months2018-07-01 to 2018-09-30 | $439.7k | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2018-01-01 to 2018-09-30 | $1.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2018-07-01 to 2018-09-30 | $2.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2018-01-01 to 2018-09-30 | $4.8m | us-gaap:GrossProfit |
| Operating income | 3 months2018-07-01 to 2018-09-30 | −$385.6k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-01-01 to 2018-09-30 | −$1.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-07-01 to 2018-09-30 | $147.7k | us-gaap:InterestExpense |
| Interest expense | 9 months2018-01-01 to 2018-09-30 | $205.2k | us-gaap:InterestExpense |
| Net income | 3 months2018-07-01 to 2018-09-30 | −$496.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-01-01 to 2018-09-30 | −$475.7k | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2018-07-01 to 2018-09-30 | 44,436,030 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2018-01-01 to 2018-09-30 | 43,708,092 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2018-01-01 to 2018-09-30 | −$489.2k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2018-09-30 | $407.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-09-30 | $1.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-09-30 | $1.9m | us-gaap:Assets |
| Current liabilities | At period end2018-09-30 | $699.9k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2018-09-30 | $1.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-18-016895. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.